The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C. Hsieh, Davide Ruggero, Yi Liu et al.|Nature|2012Cited by 1.4k
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Raymond J. Lim, Melissa A Chavez et al.|Nature Medicine|2010Cited by 338
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cellsMichael G. Kharas, Matthew R. Janes, Vanessa M. Scarfone et al.|Journal of Clinical Investigation|2008Cited by 150